By Dr Kevin Ni

Conference Papers

Bai X; Ni J; Li Y; Beretov J, 2020, 'Abstract 6163: Integrated stress response contributes to triple negative breast cancer radioresistance by regulating glutathione biosynthesis', in Cancer Research, American Association for Cancer Research (AACR), pp. 6163 - 6163, http://dx.doi.org/10.1158/1538-7445.am2020-6163

Bai X; Feng X; Ni J; Beretov J; Deng J; Zhu Y; Graham P; Li Y, 2019, 'Abstract 4754: CHTOP is a novel therapeutic target for chemoresistant epithelial ovarian cancer therapy', in Cancer Research, American Association for Cancer Research (AACR), pp. 4754 - 4754, http://dx.doi.org/10.1158/1538-7445.am2019-4754

Ni J; Cozzi P; Beretov J; Bucci J; Graham P; Li Y, 2018, 'Abstract 1999: Study of CD44 variant 6 (CD44v6) in prostate cancer chemo-/radio resistance in vivo', in Cancer Research, American Association for Cancer Research (AACR), pp. 1999 - 1999, http://dx.doi.org/10.1158/1538-7445.am2018-1999

Ni J; Cozzi P; Beretov J; Deng J; Bucci J; Graham P; Li Y, 2017, 'Abstract 2833: Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer progression and chemo-/radio-resistance in   vitro and in vivo', in Cancer Research, American Association for Cancer Research (AACR), pp. 2833 - 2833, http://dx.doi.org/10.1158/1538-7445.am2017-2833

Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Delprado W; Graham P; Bucci J; Kearsley J; Li Y, 2014, 'Abstract 4005: CD44 isoform variant 6 is associated with prostate cancer progression, metastasis and chemo-/radio-resistance via PI3K/Akt/mTOR and Wnt/β-catenin signaling pathways in vitro', in Cancer Research, American Association for Cancer Research (AACR), pp. 4005 - 4005, http://dx.doi.org/10.1158/1538-7445.am2014-4005

Back to profile page